EMEA Symposium Focuses on Optimizing Outcomes
For patients with colorectal cancer or inflammatory bowel diseases, such as Crohn’s Disease and Ulcerative Colitis, surgery can be the best path to a potential cure or symptom control. At the second Johnson & Johnson Institute EMEA Colorectal Surgery Symposium in Hamburg, Germany, more than 275 surgeon leaders came together to share learnings and knowledge to advance care for these patients with a focus on optimizing outcomes.
A combination of thought-provoking speakers engaged audience members and tech tools made for a highly-interactive, educational forum. Participants were equipped with a polling device so that consensus and discrepancies could be revealed, and a chatting function allowed questions and comments to be submitted to the stage for discussion. In addition, “Meet the Expert” break-out sessions provided for small group interaction and access to key opinion leaders.
“Our goal at ETHICON is to help surgeons optimize clinical outcomes for all patients. Through the Johnson & Johnson Institute we partner with thought-leading surgeons to bring together the best research, innovation and education to help realize that goal, “said Joe Schowalter, Director Colorectal Specialty, Global Strategic Marketing. ”We sincerely appreciate the opportunity to engage with such an impressive group of colorectal surgeons at this symposium and we look forward to our continued collaboration.”
Reducing Anastomotic Leaks
Diseases of the colon and rectum can be complex to treat. Any initiative to improve surgical care must focus on reducing the risk of complications and associated costs. During the symposium, there was a focus on the latest research and procedural techniques to reduce the risk of anastomotic leaks. This significant complication of colorectal surgery is associated with considerable morbidity and patient suffering, as well as increased hospitalization.
Members of the European Society of Coloproctology (ESCP) provided an update on an initiative to develop online training tools to help standardize surgical techniques for anastomosis and then measure the impact of those tools on surgical behavior and patient-level outcomes. The ESCP EAGLE study cohort is scheduled to be launched in September. Click here to learn more about the launch of the initiative at the 2018 ESCP annual meeting.
Organ Preservation Strategies
The potential morbidity associated with resection for rectal and colon cancers has led leading surgeons to adopt strategies aimed at organ preservation. The risk and benefits of the approaches were discussed and debated with the goal of advancing practice to improve patient outcomes and quality of life.
“Surgery can offer patients with colorectal illnesses the best hope for a potential cure or improved quality of life.” said Ludwig Groebler, Manager, Professional Education, Colorectal Specialty “The Johnson & Johnson Institute is committed to collaborating with surgeon leaders to deliver professional education and training focused on optimizing outcomes, improve patient satisfaction and reducing the costs of treatment.”
What attendees had to say about their experience at the 2019 Johnson & Johnson Institute Colorectal Surgery Symposium
“I really enjoyed the academic content and the entire meeting and philosophy of changing practice worked really well. Great use of technology for voting etc. Obviously, the product of a lot of hard work- it paid off.”
“The meeting: probably the best which I could attend over the last couple of years, excellent talks and opposite to other congresses, where the main key opinion leaders do not permit real controversies and one is just echoing the other, there were many new approaches such as radiochemo for early rectumcarcinoma, local excision after radiochemo, critical view on TAMIS.”
“Fantastic! I think that this symposium can become the place to be every year for colorectal surgery. “